Literature DB >> 21286215

Endothelium-derived hyperpolarizing factor and diabetes.

Xue Gao1, Luis A Martinez-Lemus, Cuihua Zhang.   

Abstract

In addition to its role as a barrier between blood and tissues, the vascular endothelium is responsible for the synthesis and released of a number of vasodilators including prostaglandins, nitric oxide and endothelium-derived hyperpolarizing factor (EDHF). As one of these vasodilators, the specific nature of EDHF has not been fully elucidated, although a number of roles have been proposed. Importantly, many conditions, such as hypertension, hyperlipidemia, heart failure, ischemia-reperfusion and diabetes mellitus comprise vascular endothelial dysfunction with EDHF dysregulation. This article reviews reports on the role of EDHF in diabetes-related endothelial dysfunction.

Entities:  

Keywords:  Endothelial-dysfunction; Epoxyeicosatrienoic acids; Hydrogen peroxide; Hyperglycemia; Potassium channels

Year:  2011        PMID: 21286215      PMCID: PMC3030734          DOI: 10.4330/wjc.v3.i1.25

Source DB:  PubMed          Journal:  World J Cardiol


  77 in total

Review 1.  Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone.

Authors:  W B Campbell; D R Harder
Journal:  Circ Res       Date:  1999-03-05       Impact factor: 17.367

Review 2.  Endothelium-derived hyperpolarizing factor.

Authors:  K Komori; P M Vanhoutte
Journal:  Blood Vessels       Date:  1990

Review 3.  The alternative: EDHF.

Authors:  M Félétou; P M Vanhoutte
Journal:  J Mol Cell Cardiol       Date:  1999-01       Impact factor: 5.000

4.  Role of endothelium-derived hyperpolarizing factor in human forearm circulation.

Authors:  Kosuke Inokuchi; Yoshitaka Hirooka; Hiroaki Shimokawa; Koji Sakai; Takuya Kishi; Koji Ito; Yoshikuni Kimura; Akira Takeshita
Journal:  Hypertension       Date:  2003-10-13       Impact factor: 10.190

5.  Mechanisms of action of noradrenaline and carbachol on smooth muscle of guinea-pig anterior mesenteric artery.

Authors:  T B Bolton; R J Lang; T Takewaki
Journal:  J Physiol       Date:  1984-06       Impact factor: 5.182

6.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

7.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

8.  Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice.

Authors:  Malarvannan Pannirselvam; Valerie Simon; Subodh Verma; Todd Anderson; Chris R Triggle
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

9.  Mediation of vascular relaxation in epineurial arterioles of the sciatic nerve: effect of diabetes in type 1 and type 2 diabetic rat models.

Authors:  Lawrence J Coppey; Jill S Gellett; Mark A Yorek
Journal:  Endothelium       Date:  2003

10.  Alterations in EDHF-type relaxation and phosphodiesterase activity in mesenteric arteries from diabetic rats.

Authors:  Takayuki Matsumoto; Tsuneo Kobayashi; Katsuo Kamata
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-07       Impact factor: 4.733

View more
  9 in total

Review 1.  The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update.

Authors:  Hanrui Zhang; Kevin C Dellsperger; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2011-12-22       Impact factor: 17.165

2.  Sexual dimorphism in rat aortic endothelial function of streptozotocin-induced diabetes: possible involvement of superoxide and nitric oxide production.

Authors:  Xiaoyuan Han; Rui Zhang; Leigh Anderson; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2013-11-06       Impact factor: 4.432

3.  Sex differences in mesenteric endothelial function of streptozotocin-induced diabetic rats: a shift in the relative importance of EDRFs.

Authors:  Rui Zhang; Der Thor; Xiaoyuan Han; Leigh Anderson; Roshanak Rahimian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-09-14       Impact factor: 4.733

Review 4.  Endothelial small-conductance and intermediate-conductance KCa channels: an update on their pharmacology and usefulness as cardiovascular targets.

Authors:  Heike Wulff; Ralf Köhler
Journal:  J Cardiovasc Pharmacol       Date:  2013-02       Impact factor: 3.105

Review 5.  Vascular endothelial dysfunction and pharmacological treatment.

Authors:  Jin Bo Su
Journal:  World J Cardiol       Date:  2015-11-26

6.  Effect of rosuvastatin on hyperuricemic rats and the protective effect on endothelial dysfunction.

Authors:  Dilidaer Xilifu; Abulizi Abudula; Nijiati Rehemu; Long Zhao; Xinrong Zhou; Xiangyang Zhang
Journal:  Exp Ther Med       Date:  2014-10-15       Impact factor: 2.447

7.  30-days effects of vildagliptin on vascular function, plasma viscosity, inflammation, oxidative stress, and intestinal peptides on drug-naïve women with diabetes and obesity: a randomized head-to-head metformin-controlled study.

Authors:  Alessandra Schiapaccassa; Priscila A Maranhão; Maria das Graças Coelho de Souza; Diogo G Panazzolo; José Firmino Nogueira Neto; Eliete Bouskela; Luiz Guilherme Kraemer-Aguiar
Journal:  Diabetol Metab Syndr       Date:  2019-08-23       Impact factor: 3.320

8.  Intense exercise training is not effective to restore the endothelial NO-dependent relaxation in STZ-diabetic rat aorta.

Authors:  Mohamed Sami Zguira; Sophie Vincent; Solène Le Douairon Lahaye; Ludivine Malarde; Zouhair Tabka; Bernard Saïag
Journal:  Cardiovasc Diabetol       Date:  2013-02-11       Impact factor: 9.951

9.  Endothelium-Derived Hyperpolarizing Factors: A Potential Therapeutic Target for Vascular Dysfunction in Obesity and Insulin Resistance.

Authors:  Guanghong Jia; William Durante; James R Sowers
Journal:  Diabetes       Date:  2016-08       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.